GlaxoSmithKline is beefing up its pharmaceuticals business with the acquisition of Tesaro for its strength in cancer treatment drugs, and that’s just the beginning.
Pfizer has stopped its research on the possible cure for Parkinson's and Alzheimer's diseases.